{"id":31161,"date":"2022-03-14T15:44:59","date_gmt":"2022-03-14T07:44:59","guid":{"rendered":"http:\/\/biopioneer.com.tw\/?p=31161"},"modified":"2022-07-19T11:51:37","modified_gmt":"2022-07-19T03:51:37","slug":"%e3%80%90omicron-%e8%ae%8a%e7%95%b0%e6%a0%aa%e9%87%8d%e7%b5%84%e8%9b%8b%e7%99%bd%e3%80%91assay-genie-sars-cov-2-recombinant-proteins","status":"publish","type":"post","link":"http:\/\/biopioneer.com.tw\/?p=31161","title":{"rendered":"\u3010Omicron \u8b8a\u7570\u682a\u91cd\u7d44\u86cb\u767d\u3011Assay Genie SARS-CoV-2 Recombinant Proteins"},"content":{"rendered":"

\u3010Omicron \u8b8a\u7570\u682a\u91cd\u7d44\u86cb\u767d\u3011Assay Genie SARS-CoV-2 Recombinant Proteins<\/p>\n

\"\"<\/p>\n

Assay Genie SARS-CoV-2 Recombinant Proteins<\/p>\n

With the rapid progression of the global pandemic, COVID-19, there has been the development of innovative drug & vaccine RnD strategies to battle and overcome this infectious disease. At Assay Genie we have developed\u00a0over 60\u00a0\u00a0novel recombinant proteins for SARS-CoV-2 as well as new variants such as\u00a0Japan<\/a>,\u00a0UK<\/a>,\u00a0South Africa<\/a>,\u00a0Brazil<\/a>\u00a0and others\u00a0<\/strong>to aid COVID-19 Research.<\/p>\n

Why choose Assay Genie SARS-CoV-2 recombinant proteins?<\/p>\n

Our proteins are highly pure, ranging between 90-98% in purity. They are also physiologically relevant; Assay Genie recombinant proteins are mostly expressed in mammalian expression systems, meaning that they are synthesized, processed, and secreted in a manner similar to in humans. For this reason, as well as the fact they have been shown to have low endotoxin, our recombinant proteins do not elicit an immune response\u00a0in vivo.\u00a0This makes ELISA Genie recombinant proteins hugely relevant to the area of vaccine development for COVID-19.<\/p>\n

Types of SARS-CoV-2 recombinant proteins available<\/p>\n

We have synthesized recombinant versions of the key proteins involved in the process of viral infection by COVID-19. These include the integral proteins expressed on the surface of the coronavirus; spike (S) protein, envelope (E) protein, and nucleocapsid protein (N).We have also created recombinant proteins of other proteins involved in the mechanism of infection with coronavirus. These include proteinases, proteases, and helicases essential for coronaviral replication and host cell invasion, as well as human proteins implicated in coronavirus uptake into host cells, such as CD147\/Basigin Protein, APN Protein, and the human receptor for SARS-CoV-2; ACE2.
\nOur recombinant proteins allow scientists to both recapitulate the endogenous activity of key proteins involved in coronavirus infection, as well as develop potential therapies by targeting such proteins.<\/p>\n

Variant SARS-CoV-2 recombinant proteins<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Sku<\/strong><\/td>\nProduct Name<\/strong><\/td>\nVariant<\/strong><\/td>\nVirus<\/strong><\/td>\n<\/tr>\n<\/thead>\n
RPES5258<\/td>\nOmicron S1+S2 trimer Recombinant Protein (C-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5251<\/td>\nOmicron Nucleocapsid Recombinant Protein (N-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5252<\/td>\nOmicron S1+S2 Recombinant Protein (ECD, C-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5253<\/td>\nOmicron Spike S1 NTD Recombinant Protein (ECD, C-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5254<\/td>\nOmicron Spike RBD Recombinant Protein (mFc Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5255<\/td>\nOmicron Spike RBD Recombinant Protein (N-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5256<\/td>\nOmicron Spike RBD Recombinant Protein (C-hFc Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5257<\/td>\nOmicron Spike RBD Recombinant Protein (C-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5259<\/td>\nOmicron Spike RBD Recombinant Protein (C-6His-Avi), Biotinylated<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES5260<\/td>\nOmicron Spike S1 Recombinant Protein (C-His Tag)<\/a><\/td>\nOmicron<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPCO00011<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (D63G,R203M,D377Y) (Active)<\/a><\/td>\nDelta<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
DC0007150<\/td>\nRecombinant SARS-CoV-2 Spike RBD Variant 501Y.V1<\/a><\/td>\nAlpha<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
DC0007151<\/td>\nRecombinant SARS-CoV-2 Spike RBD Variant 501Y.V2<\/a><\/td>\nBeta<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
DC0007152<\/td>\nRecombinant SARS-CoV-2 Spike RBD Variant 501Y.V3<\/a><\/td>\nGamma, V3<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
PACOV0016<\/td>\nRecombinant Novel Coronavirus Spike glycoprotein(S) (Active)<\/a><\/td>\nE484K<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPES0068<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, mFc Tag)<\/a><\/td>\nV367F<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0069<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)<\/a><\/td>\nV367F<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0070<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)<\/a><\/td>\nK458R<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0071<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)<\/a><\/td>\nF342<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0072<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)<\/a><\/td>\nV483A<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0073<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)<\/a><\/td>\nA435S<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0074<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)<\/a><\/td>\nN354D<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0075<\/td>\nRecombinant 2019-nCoV S1 Protein (His Tag) (Active)<\/a><\/td>\nD614G<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0077<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag) (Active)<\/a><\/td>\nG476S<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0078<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag) (Active)<\/a><\/td>\nW436R<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00001<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (T205I) (Active)<\/a><\/td>\nT205I<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPCO00002<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (P80R) (Active)<\/a><\/td>\nP80R<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPCO00003<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (P13L) (Active)<\/a><\/td>\nP13L<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPCO00004<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (D103Y) (Active)<\/a><\/td>\nD103Y<\/td>\nSARS-CoV-2<\/td>\n<\/tr>\n
RPCO00005<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (S202N) (Active)<\/a><\/td>\nS202N<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00006<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (L230F) (Active)<\/a><\/td>\nL230F<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00007<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (I292T) (Active)<\/a><\/td>\nI292T<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00008<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (Q384H) (Active)<\/a><\/td>\nQ384H<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00009<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (R203K,G204R) (Active)<\/a><\/td>\nR203K,G204R<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00010<\/td>\nRecombinant Human Novel Coronavirus Nucleoprotein (N) (R203M,D377Y) (Active)<\/a><\/td>\nR203M,D377Y<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00012<\/td>\nRecombinant Human Novel Coronavirus Spike glycoprotein (S) (E484K), partial (Active)<\/a><\/td>\nE484K<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00013<\/td>\nRecombinant Human Novel Coronavirus Spike glycoprotein (S) (K417N), partial<\/a><\/td>\nK417N<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00014<\/td>\nRecombinant Human Novel Coronavirus Spike glycoprotein (S) (N501Y), partial (Active)<\/a><\/td>\nN501Y<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00015<\/td>\nRecombinant Human Novel Coronavirus Spike glycoprotein (S) (K417T), partial<\/a><\/td>\nK417T<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00016<\/td>\nRecombinant Human Novel Coronavirus Spike glycoprotein (S) (K417N,E484K,N501Y), partial<\/a><\/td>\nK417N,E484K,N501Y<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPCO00017<\/td>\nRecombinant Human Novel Coronavirus Spike glycoprotein (S) (D614G), partial (Active)<\/a><\/td>\nD614G<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0068<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, mFc Tag)(V367F)<\/a><\/td>\nArg319-Phe541(V367F)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0069<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(V367F)<\/a><\/td>\n(Arg319-Phe541)(V367F)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0070<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(K458R)<\/a><\/td>\n(Arg319-Phe541)(K458R)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0071<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(F342L)<\/a><\/td>\n(Arg319-Phe541)(F342L)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0072<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(V483A)<\/a><\/td>\n(Arg319-Phe541)(V483A)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0073<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(A435S)<\/a><\/td>\n(Arg319-Phe541)(A435S)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0074<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(N354D)<\/a><\/td>\n(Arg319-Phe541)(N354D)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0075<\/td>\nRecombinant 2019-nCoV S1 Protein (His Tag)(D614G)(Active)<\/a><\/td>\nVal16-Arg685(D614G)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0076<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(G476S)(Active)<\/a><\/td>\nVal16-Arg685<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0077<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(G476S)(Active)<\/a><\/td>\nArg319-Phe541(G476S)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n
RPES0078<\/td>\nRecombinant 2019-nCoV Spike Protein (RBD, His Tag)(W436R)(Active)<\/a><\/td>\nArg319-Phe541(W436R)<\/td>\nSARS-Cov-2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

\u3010Omicron \u8b8a\u7570\u682a\u91cd\u7d44\u86cb\u767d\u3011Assay Genie SARS-CoV-2 Recombinant Pro […]<\/p>\n","protected":false},"author":3,"featured_media":31162,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[3,461],"tags":[958],"_links":{"self":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/31161"}],"collection":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31161"}],"version-history":[{"count":2,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/31161\/revisions"}],"predecessor-version":[{"id":31372,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/31161\/revisions\/31372"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/31162"}],"wp:attachment":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31161"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}